Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. VTRS
VTRS logo

VTRS Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Viatris Inc (VTRS) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
15.370
1 Day change
-2.29%
52 Week Range
17.530
Analysis Updated At
2026/06/19
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Viatris Inc (VTRS) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the stock has some positive analyst ratings and potential catalysts, the technical indicators and trading sentiment suggest a lack of immediate upward momentum. Additionally, hedge fund selling and a lack of significant insider activity or recent congress trading data further reduce confidence in the stock as a compelling buy right now.

Technical Analysis

The MACD is negative and expanding (-0.0945), indicating bearish momentum. RSI is at 29.242, which is neutral but leaning toward oversold territory. Moving averages are converging, suggesting indecision in price direction. Key support is at 15.212, and resistance is at 16.503. The stock is trading near support levels.

Options Data

Bullish
Open Interest Put-Call Ratio
Bearish
Option Volume Put-Call Ratio

The high put-call volume ratio (3.25) indicates bearish sentiment among options traders, with more puts being traded relative to calls.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
7
Buy
6

Positive Catalysts

  • Analysts have raised price targets recently, with Barclays increasing the target to $22 and Truist to $20, citing strong Q1 results and potential for future growth. The company is expected to benefit from product approvals and revenue growth in the coming years.

Neutral/Negative Catalysts

  • Hedge funds are selling heavily, with a 247.32% increase in selling activity over the last quarter. No recent news, insider activity, or congress trading data to provide additional confidence. Technical indicators suggest bearish momentum.

Financial Performance

No financial data available for analysis. However, analysts have highlighted a 5% revenue beat and 10% operational EBITDA growth in Q1, indicating some positive financial trends.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analyst sentiment is generally positive, with multiple firms raising price targets and maintaining Buy or Overweight ratings. However, JPMorgan remains Neutral, reflecting some caution.

Wall Street analysts forecast VTRS stock price to fall
4 Analyst Rating
Wall Street analysts forecast VTRS stock price to fall
2 Buy
1 Hold
1 Sell
Hold
Current: 15.730
sliders
Low
10
Averages
13.25
High
16
Current: 15.730
sliders
Low
10
Averages
13.25
High
16
Barclays
Glen Santangelo
Overweight
maintain
$17 -> $22
AI Analysis
2026-05-19
Reason
Barclays
Glen Santangelo
Price Target
$17 -> $22
AI Analysis
2026-05-19
maintain
Overweight
Reason
Barclays analyst Glen Santangelo raised the firm's price target on Viatris to $22 from $17 and keeps an Overweight rating on the shares. The company reported "strong" Q1 results and believes a slate of product approvals this year will "lay the foundation" for accelerating growth in fiscal 2027. With Viatris closing the revenue growth gap to peers, the stock's multiple should "keep grinding higher," the analyst tells investors in a research note.
Truist
Buy
maintain
$18 -> $20
2026-05-08
Reason
Truist
Price Target
$18 -> $20
2026-05-08
maintain
Buy
Reason
Truist raised the firm's price target on Viatris to $20 from $18 and keeps a Buy rating on the shares. The company's Q1 results featuring a 5% revenue beat and 10% operational EBITDA growth represent a clear pivot point for investors who have sidelined the name while awaiting proof of consistent execution, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for VTRS
Unlock Now

People Also Watch